Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types-Reference-Cited by-同舟云学术

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types

Published:2011-11 Issue:12 Volume:12 Page:1162-1168
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Loi Sherene,Symmans W Fraser,Bartlett John MS,Fumagalli Debora,Veer Laura Van't,Forbes John F,Bedard Philippe,Denkert Carsten,Zujewski JoAnne,Viale Giuseppe,Pusztai Lajos,Esserman Laura J,Leyland-Jones Brian R

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

2. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

3. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2006

4. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC);Arnedos;Ann Oncol,2009

5. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies;Lebeau;J Clin Oncol,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creating an Annotated Biospecimen Resource for Liquid Biopsy Applications;Circulating Tumor Cells;2023

2. Current Standard Clinical Predictive Markers;A Comprehensive Guide to Core Needle Biopsies of the Breast;2022

3. Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta‐aggregation;The Journal of Pathology: Clinical Research;2021-02-26

4. Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial;Annals of Oncology;2019-11

5. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference;Journal of Cancer;2018